Volume: 30mL multi-dose vial
Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome
Post ischemia intermittent hypoxia induces hippocampal neurogenesis and synaptic alterations and alleviates long-term memory impairment
As an investigational drug, dosing protocols are strictly controlled within clinical settings and should not be replicated outside of supervised trials
After applying eligibility criteriaincluding documented weight reduction within one year prior to fertility treatment, no history of bariatric surgery or prior pregnancy, complete BMI data and no use of other anti-obesity medications (liraglutide, exenatide, dulaglutide, orlistat)eligible patients were stratified into three BMI categories: overweight (25.029.9 kg/m), obese class I (30.034.9 kg/m), and obese class IIIII ( 35.0 kg/m)
[15] [16] Your diabetes team will advise on ketone testing if you are at higher risk